Health Condition 1: null- Vitiligo (Any type)
Conditions
Interventions
Intervention1: Group-A: UNIM-044(O), UNIM044(L) with MM Therapy: Initially patient is admitted in IPD of CRIUM for MM Therapy that is UNIM-040+041+042: 35 grams of the Munzij (coctive) drug was soake
Sponsors
Director General CCRUM
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with clinically diagnosed Vitiligo. 2. Age â?? 9 to 60 years 3. Either gender 4. With any duration of disease, site, extension and distribution of lesions. 5. Willingness to give written consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with Hepato-renal, cardiac and pulmonary malfunction. 2. Patients on active Vitiligo treatment with other drugs/systems. 3. Subjects with other skin disease. 4. Subjects with known allergies 5. Subjects those who are unwilling to come for regular follow-ups for the entire duration of study. 6. Non-co-operative patients. Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response is assessed in the form of percentage and gradingTimepoint: Baseline, 2nd month, 4th month, 6th month, 8th month | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety measures by pathological and biochemical investigationsTimepoint: Baseline, Before MM Therapy , after MM Therapy(45 days), At the end of trial | — |
Countries
India
Contacts
Public ContactAhmad Minhajuddin
Outcome results
None listed